Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey
Feldman DI, Valero-Elizondo J, Salami JA, Rana JS, Ogunmoroti O, Okunrintemi V, Osondu CU, Spatz ES, Virani SS, Blankstein R, Blaha MJ, Veledar E, Nasir K. Is diabetes mellitus equivalent to atherosclerotic cardiovascular disease from a healthcare cost perspective? Insights from the Medical Expenditure Panel Survey. Cardiovascular Endocrinology & Metabolism 2018, 7: 64-67. PMID: 31646284, PMCID: PMC6739895, DOI: 10.1097/xce.0000000000000151.Peer-Reviewed Original ResearchAtherosclerotic cardiovascular diseaseDiabetes mellitusMedical Expenditure Panel SurveyCardiovascular diseaseMajor adverse cardiac eventsAggressive therapeutic managementAdverse cardiac eventsLower healthcare expendituresCardiac eventsSecondary preventionTherapeutic managementHealthcare costsEconomic burdenProper lifestyleHealthcare expendituresHousehold ComponentMellitusPanel SurveyDiseasePriority conditionsResource utilizationCliniciansDiagnosisIndividualsPrevention